CX3CL1 expression is associated with poor outcome in breast cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CX3CL1 expression is associated with poor outcome in breast cancer patients
Authors
Keywords
CX3CL1, Biomarker, Patients survival, Breast cancer
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 140, Issue 3, Pages 495-504
Publisher
Springer Nature
Online
2013-08-03
DOI
10.1007/s10549-013-2653-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fractalkine: A Survivor's Guide
- (2012) Gemma E. White et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
- (2012) Julia Y. S. Tsang et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
- (2012) D H Morrison et al. BRITISH JOURNAL OF CANCER
- CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
- (2012) A Dubrovska et al. BRITISH JOURNAL OF CANCER
- High Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma
- (2012) Xianhui Xu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- CX3 CL1/fractalkine is a novel regulator of normal and malignant human B cell function
- (2012) Anna Corcione et al. JOURNAL OF LEUKOCYTE BIOLOGY
- High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma
- (2012) Min Ho Park et al. JOURNAL OF SURGICAL ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- αB-crystallin, a small heat shock protein, modulates NF-κB activity in a phosphorylation-dependent manner and protects muscle myoblasts from TNF-α induced cytotoxicity
- (2011) Amit S. Adhikari et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- Identification of the Chemokine CX3CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer
- (2011) Françoise Gaudin et al. PLoS One
- Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1
- (2010) Marco Erreni et al. EUROPEAN JOURNAL OF CANCER
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1
- (2010) Giuseppe Sciumè et al. NEURO-ONCOLOGY
- Constitutive Endocytosis of the Chemokine CX3CL1 Prevents Its Degradation by Cell Surface Metalloproteases
- (2009) Yi-Wei Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Increased Expression of Fractalkine is Correlated with a Better Prognosis and an Increased Number of Both CD8+ T Cells and Natural Killer Cells in Gastric Adenocarcinoma
- (2008) Miki Hyakudomi et al. ANNALS OF SURGICAL ONCOLOGY
- The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
- (2008) Federica Marchesi et al. CANCER RESEARCH
- Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-κB
- (2008) Pankaj K. Bhavsar et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started